Literature DB >> 51442

Letter: Clozapine and agranulocytosis.

J Idänpään-Heikkilä, E Alhava, M Olkinuora, I Palva.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51442     DOI: 10.1016/s0140-6736(75)90206-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

Review 1.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia.

Authors:  Y-T Xiang; G S Ungvari; C U Correll; H F K Chiu; N Shinfuku
Journal:  Epidemiol Psychiatr Sci       Date:  2015-08-20       Impact factor: 6.892

Review 3.  Continuing clozapine treatment despite neutropenia.

Authors:  David Esposito; Frédéric Rouillon; Frédéric Limosin
Journal:  Eur J Clin Pharmacol       Date:  2004-11-30       Impact factor: 2.953

4.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

5.  Clozapine-induced agranulocytosis. A genetic and epidemiologic study.

Authors:  A de la Chapelle; C Kari; M Nurminen; S Hernberg
Journal:  Hum Genet       Date:  1977-06-30       Impact factor: 4.132

6.  Changes for clozapine monitoring in the United States.

Authors:  T Bastiampillai; A Gupta; S K W Chan; S Allison
Journal:  Mol Psychiatry       Date:  2016-05-03       Impact factor: 15.992

7.  Survey of the spontaneous adverse drug reaction reporting schemes in fifteen countries.

Authors:  J P Griffin
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

8.  What's new in the psychopharmacology of schizophrenia.

Authors:  A Rifkin; F Quitkin
Journal:  Bull N Y Acad Med       Date:  1978-10

9.  The atypical antipsychotic clozapine impairs insulin secretion by inhibiting glucose metabolism and distal steps in rat pancreatic islets.

Authors:  N Sasaki; M Iwase; Y Uchizono; U Nakamura; H Imoto; S Abe; M Iida
Journal:  Diabetologia       Date:  2006-10-27       Impact factor: 10.122

10.  Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.

Authors:  M Pirmohamed; K Park
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.